Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
J3 Bioscience
AddedFeb 17, 2024
UpdatedJun 18, 2026
J3 Bioscience

J3 Bioscience

J3 Bioscience develops long-lasting, hormone-free biomedical devices for improved female reproductive health and comfort.

HQ
Salt Lake City, UT, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

J3 Bioscience, founded with a mission to enhance female reproductive health, focuses on developing innovative biomedical devices. The company's core product, the LivRing™, is a hormone-free intravaginal ring designed to provide continuous moisture and lubrication for up to seven days. This FDA-cleared device aims to improve vaginal health and comfort, particularly during intimate activities. J3 Bioscience targets the women's health and wellness market, addressing a significant need for effective and long-lasting vaginal health solutions.

Notable figures associated with J3 Bioscience include experts in biomedical engineering and women's health, contributing to the company's credibility and innovation. The company has secured patents for its LivRing™ and achieved FDA clearance, marking significant milestones in its journey. J3 Bioscience's impact lies in providing a safe, effective, and convenient solution for vaginal health, potentially improving the quality of life for many women.

J3 Bioscience - Similar Companies

INVO Fertility logo

INVO Fertility

invobioscience.com

Bioceptive logo

Bioceptive

bioceptive.com

Biomirror Diagnostics logo

Biomirror Diagnostics

Evofem Biosciences logo

Evofem Biosciences

evofem.com

3Daughters logo

3Daughters

JangoBio logo

JangoBio

jango.bio

Jyzen logo

Jyzen

jyzen.com

Circe Biomedical logo

Circe Biomedical

Juvent - Regenerative Technologies logo

Juvent - Regenerative Technologies

juvent.com

Kiffik Biomedical logo

Kiffik Biomedical

kiffik.com

V-Flow Medical logo

V-Flow Medical

Joylux logo

Joylux

joylux.com

enVVeno Medical logo

enVVeno Medical

envveno.com

viO HealthTech logo

viO HealthTech

viohealthtech.com

Rejoni logo

Rejoni

rejoni.com

J3 Bioscience - Quick Facts

Who are J3 Bioscience's competitors?

Companies similar to J3 Bioscience include INVO Fertility, Bioceptive, Biomirror Diagnostics and Evofem Biosciences.

When was J3 Bioscience founded?

J3 Bioscience was founded in 2011.

Where is J3 Bioscience's headquarters located?

J3 Bioscience's headquarters is located in Salt Lake City, UT, US.

When was J3 Bioscience's last funding round?

J3 Bioscience's most recent funding round was for $291.8k (USD) in October 2022.

How much has J3 Bioscience raised to-date?

As of Oct 20, 2022, J3 Bioscience has raised a total of $2.8M (USD).

How many employees does J3 Bioscience have?

J3 Bioscience has 10 employees as of Feb 5, 2024.

J3 Bioscience - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified